The move aimed at helping boost production as demand currently outstrips supply.
“The agreement will see Novartis utilizing its aseptic manufacturing facilities at its site in Stein, Switzerland,” Novartis said in a statement on Friday. External link
“Subject to reaching a final agreement, Novartis plans to commence production in the second quarter of 2021.”
This is the first of multiple agreements “to leverage manufacturing capacity and capabilities to address pandemic, supporting global supply of Covid-19 vaccine” being explored by Novartis, the company said.
The Pfizer-BioNTech Covid-19 Vaccine has been authorised for use by the health regulatory authorities of about 50 countries, including Switzerland. It has also received authorisations for emergency use countries like the United Kingdom and the United States.
Switzerland will be affected by the temporary delay to the Pfizer-BioNTech Covid-19 vaccine in Europe, the Swiss health authorities have already confirmed.
Moderna has warned Switzerland that its Covid-19 vaccine deliveries would be delayed, the Swiss Federal Office of Public Health said on Thursday. This will lead to a shortfall in February that the Swiss expect the US company to make up in March, Reuters has reported.External link
Popular Stories
More
Swiss Abroad
How centuries of Swiss emigrants left their mark on the US
Bodycams: essential for good law enforcement, or a privacy risk?
Did you ever come across bodycams in your place of residence and if so, how do you think the use of bodycams alter the relationship between the public and (transport) police?
This content was published on
Swiss wheelchair racer Catherine Debrunner won the 5,000 metres to bring home Switzerland’s first gold medal at the Paralympics in Paris.
This content was published on
Switzerland will be affected by the temporary delay to the Pfizer-BioNTech Covid-19 vaccine in Europe, the Swiss health authorities have confirmed.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.